Telodown Tablet 40/20 Milligrams
Telmisartan 40mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Il-Yang Pharmaceutical Co., Ltd.
MFDS item code 201906986 · Approved 2019.09.30
This product's status changed to Expired on 2025.10.31. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of hypertension, improvement of dyslipidemia, and inhibition of cardiovascular disease risk and atherosclerosis progression
This medication is used for patients who need to take two medications, telmisartan and rosuvastatin, simultaneously. Telmisartan primarily treats essential hypertension and helps reduce the risk of myocardial infarction, stroke, and death due to cardiovascular disease in high-risk cardiovascular disease patients. Rosuvastatin is used as an adjunct to diet for primary and mixed hyperlipidemia, as well as familial hypercholesterolemia patients, lowering total cholesterol and LDL cholesterol to slow the progression of atherosclerosis. Additionally, it is effective in reducing the risk of stroke, myocardial infarction, and arterial revascularization in high-risk cardiovascular disease patients. Therefore, this medication is used to manage both hypertension and hyperlipidemia while lowering the risk of cardiovascular disease.
This medication should be administered only to adults. The dosage should be individualized for each patient based on the efficacy and tolerability of each component, telmisartan and rosuvastatin. ○ Telmisartan 1. Essential hypertension Adults: The recommended dose is 40 mg of telmisartan orally once daily; 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When this medication is coadministered with a thiazide diuretic such as hydrochlorothiazide, it produces an additional blood pressure-lowering effect. When increasing the dose, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. 2. Reduction of cardiovascular risk Adults: The recommended dose of this medication is 80 mg orally once daily. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this medication to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive agents may be required. 3. Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily. ○ Rosuvastatin calcium 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medication and continue it throughout the treatment period. This medication may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response, and may be increased to a maximum of 20 milligrams once daily. 2. Older adults: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medication to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or below, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this medication to patients with active liver disease. 5. Race: Because systemic exposure to this medication is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients. Patients taking telmisartan and rosuvastatin concomitantly may switch to this medication (a fixed-dose combination with the same amount of each active ingredient) for convenience of administration.
This medication can cause serious harm to the fetus and newborn if given to pregnant women, so it should be discontinued immediately if pregnancy is confirmed. This medication should not be used in individuals with hypersensitivity to its components, pregnant or breastfeeding women, and fertile women who are not using effective contraception. It should not be administered to patients with severe liver dysfunction, problems with bile excretion, or specific muscle diseases. It is also deemed safe not to use in patients with severe renal impairment or when combined with specific immunosuppressants. Elderly patients, those with high serum potassium, patients with mildly impaired liver function, and patients with cardiovascular or gastrointestinal diseases should use this medication with caution. Muscle-related side effects such as myalgia or muscle weakness may occur, so patients should consult their physician immediately if any unusual symptoms arise. During the use of this medication, regular liver function tests and muscle enzyme tests should be carried out, and if any abnormal findings are observed, treatment may be discontinued. This medication can enhance the blood pressure-lowering effects when used in conjunction with other antihypertensive agents, so blood pressure and renal function should be closely monitored. Particular care should be taken if this medication is used with potassium-sparing diuretics or potassium supplements, as this can dangerously elevate potassium levels in the blood. This medication can affect liver or kidney function, so patients with these organ diseases should consult healthcare professionals before use. Additionally, since this medication may interact with some drugs, patients should inform their physician if they are taking other medications. Pregnant women or those planning to become pregnant should avoid this medication, and if pregnancy is confirmed while taking it, they should discontinue immediately. Breastfeeding women should also avoid this medication, and if necessary, discontinue breastfeeding. Safety and efficacy in children are not established, so it is not recommended for pediatric use. In case of overdose, symptoms such as hypotension, dizziness, and acute renal failure may appear, necessitating immediate medical attention. This medication may cause drowsiness or dizziness, so care should be taken when driving or operating hazardous machinery. Finally, this medication should be stored out of reach of children and should not be transferred to other containers.
Headache, position-related dizziness, sleep paralysis, increased blood pressure, decreased blood pressure, hypotension, elevated ALT, dysuria, rhinitis, discomfort in the oropharynx, pulmonary disease, unspecified gastrointestinal disease, benign gastrointestinal neoplasm, hemorrhoids, skeletal pain, osteoporosis, sensory impairment, movement disorders, atherosclerosis, frequent urination, tinnitus, hearing loss, halitosis, fatty liver, upper respiratory infection, urinary tract infection, sepsis, anemia, thrombocytopenia, eosinophilia, hypersensitivity, anaphylactic reaction, hyperkalemia, hypoglycemia, depression, insomnia, anxiety, syncope, visual disturbances, dizziness, bradycardia, tachycardia, dyspnea, abdominal pain, diarrhea, dyspepsia, abdominal distension, vomiting, abdominal discomfort, dry mouth, abnormal liver function, liver dysfunction, increased sweating, itching, rash, erythema, angioedema, drug rash, toxic skin rash, eczema, urticaria, myalgia, back pain, muscle cramps, arthralgia, limb pain, tendon pain, acute kidney failure, chest pain, weakness, influenza-like illness, increased serum creatinine, increased serum uric acid, elevated liver enzymes, increased serum CK, decreased hemoglobin, hypoglycemia, angioedema, hypersensitivity reaction including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, sexual dysfunction, gynecomastia, fatal and non-fatal hepatic failure, cognitive impairment, severe muscle weakness, ocular muscle weakness, facial spasms, sensory abnormalities, paralysis, hyperventilation, pneumonia, flushing, erectile dysfunction, anorexia, arrhythmia, weakness, facial edema, alopecia, conjunctivitis, tinnitus, petechiae, palpitations, fatigue, nausea, insufficient effect, headache, dizziness, cough, dyspepsia, palpitations, myalgia, increased CK, constipation, increased AST, weakness, joint pain, fatigue, numbness, sensory abnormalities, chest discomfort, nausea, abdominal pain, diarrhea, anorexia, abdominal distension, pruritus, abnormal liver function tests, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, arrhythmia, thrombocytopenia, increased serum creatinine, acute kidney failure, oliguria, increased serum creatinine
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is important to maintain the storage temperature between 1 and 30 degrees Celsius at room temperature.
White oval film-coated tablet
30 tablets/box [10 tablets/PTP*3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Telmisartan 40mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Il-Yang Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Yuhan Corporation.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Yuhannanghang Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Yuhan Corporation Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.